Search

Author/Creator Di Cosimo, S.

2. 1811 Expression levels of ERBB2, ESR1, immune and proliferation signatures measured by RNASeq predict response to anti-HER2 treatment in the neoALTTO trial. (September 2015)

Authors:
Sotiriou, C.; Venet, D.; Fumagalli, D.; Maetens, M.; Rothé, F.; Ignatiadis, M.; Bradbury, I.; Harbeck, N.; Gomez, H.; Chang, T.W.; Coccia-Portugal, M.A.; Di Cosimo, S.; De Azambuja, E.; De la Pena, L.; Nuciforo, P.; Armour, A.; Eidtmann, H.; Baselga, J.; Piccart, M.; Loi, S.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S269
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Anticancer innovative therapy: Highlights from the ninth annual meeting. (February 2020)

Authors:
Volpari, T.; De Santis, F.; Bracken, A.P.; Pupa, S.M.; Buschbeck, M.; Wegner, A.; Di Cosimo, S.; Lisanti, MP.; Dotti, G.; Massaia, M.; Pruneri, G.; Anichini, A.; Fortunato, O.; De Braud, F.; Del Vecchio, M.; Di Nicola, M.
Journal:
Cytokine & growth factor reviews
Issue:
Volume 51(2020)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Circulating microRNAs for early detection of therapy-related cardiac events in HER2-positive breast cancer patients: an explorative analysis from NeoALTTO. (November 2022)

Authors:
Pizzamiglio, S.; Ciniselli, C.M.; De Azambuja, E.; Agbor-Tarh, D.; Moreno-Aspitia, A.; Suter, T.; Trama, A.; Daidone, M.G.; Verderio, P.; Di Cosimo, S.
Journal:
European journal of cancer
Issue:
Volume 175(2022)Supplement 1
Page Start:
S77
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. EP-1284 Older age and comorbidity in breast cancer: is radiotherapy alone the new therapeutic frontier?. (April 2019)

Authors:
La Rocca, E.; Dispinzieri, M.; Meneghini, E.; Fiorentino, A.; Bonfantini, F.; Di Cosimo, S.; Gennaro, M.; Cosentino, V.; Sant, M.; Pignoli, E.; Valdagni, R.; Lozza, L.; De Santis, M.C.
Journal:
Radiotherapy and oncology
Issue:
Volume 133(2019)Supplement 1
Page Start:
S703
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. EP-1285 Hypofractionated irradiation in elderly breast cancer patients: an observational study. (April 2019)

Authors:
La Rocca, E.; Dispinzieri, M.; Meneghini, E.; Fiorentino, A.; Bonfantini, F.; Di Cosimo, S.; Gennaro, M.; Cosentino, V.; Sant, M.; Pignoli, E.; Valdagni, R.; Lozza, L.; De Santis, M.C.
Journal:
Radiotherapy and oncology
Issue:
Volume 133(2019)Supplement 1
Page Start:
S704
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy. (October 2016)

Authors:
De Santis, M.C.; Bonfantini, F.; Di Salvo, F.; Dispinzieri, M.; Mantero, E.; Soncini, F.; Baili, P.; Sant, M.; Bianchi, G.; Maggi, C.; Di Cosimo, S.; Agresti, R.; Pignoli, E.; Valdagni, R.; Lozza, L.
Journal:
Breast
Issue:
Volume 29(2016)
Page Start:
90
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Gene expression profile at week 2 of neoadjuvant therapy course predicts outcome in HER2-positive breast cancer patients: an explorative analysis from NeoALTTO. (November 2022)

Authors:
Di Cosimo, S.; Pizzamiglio, S.; Sotiriou, C.; Ciniselli, C.M.; Triulzi, T.; de Cecco, L.; El-Abed, S.; Izquierdo, M.; de Azambuja, E.; Saura, C.; Huober, J.; Untch, M.; Lang, I.; Loi, S.; Tagliabue, E.; Rubio, I.T.; Vingiani, A.; Colombo, M.P.; Verderio, P.; Pruneri, G.
Journal:
European journal of cancer
Issue:
Volume 175(2022)Supplement 1
Page Start:
S78
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting. (December 2018)

Authors:
De Santis, F.; Del Vecchio, M.; Castagnoli, L.; De Braud, F.; Di Cosimo, S.; Franceschini, D.; Fucà, G.; Hiscott, J.; Malmberg, K.J.; McGranahan, N.; Pietrantonio, F.; Rivoltini, L.; Sangaletti, S.; Tagliabue, E.; Tripodo, C.; Vernieri, C.; Zitvogel, L.; Pupa, S.M.; Di Nicola, M.
Journal:
Cytokine & growth factor reviews
Issue:
Volume 44(2018)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Nine-year survival outcome of neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer (NeoALTTO, BIG 1-06): final analysis of a multicentre, open-label, phase 3 randomised clinical trial. (October 2020)

Authors:
Nuciforo, P.; Townend, J.; Saura, C.; de Azumbaja, E.; Hilbers, F.; Manukyants, A.; Werutsky, G.; Bliss, J.; Moebus, V.; Colleoni, M.; Aspitia, A.Moreno; Di Cosimo, S.; Van dooren, V.; Kroep, J.; Ferro, A.; Cameron, D.; Gelber, R.; Piccart-Gebhart, M.; Huober, J.
Journal:
European journal of cancer
Issue:
Volume 138(2020)Supplement 1
Page Start:
S15
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗